‘While brain cancer may be one of the rarer cancers, the outlook for those diagnosed is bleak. For patients with glioblastoma multiforme (GBM) - the most aggressive form of brain cancer - average survival is approximately one year. However the recent supplementary approval of temozolomide for use in first-line treatment may represent the first step […]
‘The FDA has issued a non-approvable letter to Forest Laboratories in response to the company’s application for its drug Namenda to be used in the treatment of mild Alzheimer’s disease.
Namenda was approved by the FDA for the treatment of moderate to severe Alzheimer’s disease in October 2003. However, the US regulator has now raised questions […]
‘Igeneon, a unit of Aphton Corporation, has granted Celltrion a license to commercialize its anti-cancer drug candidate, IGN311, in certain Asian countries including Japan.
On top of milestone payments which could reach $6 million, Igeneon will be entitled to receive royalties from sales of IGN311 in Asia, once the drug has received marketing approval. Celltrion also […]
‘Bionutrics has finalized a deal to buy Kirk Pharmaceuticals and its affiliate, Andapharm, for $12 million in a combination of cash and debt. Kirk is a Florida-based pharmaceutical company which manufactures OTC and generic prescription drugs.’
Read more at Bionutrics to buy Kirk Pharmaceuticals for $12 million
‘Acambis has begun a phase I clinical trial of its investigational vaccine against clostridium difficile, a common hospital acquired infection that can be fatal.
C difficile infection, which is characterized by diarrhea and colitis, represents one of the most common hospital acquired infections around the world. A new virulent strain of C difficile has also emerged, […]
‘Perhaps we’re finally going to see some relief from high prescription costs. Then again, that just may be wishful thinking.
Advertisement
The reason for the optimism is that Michigan Democrats on Tuesday announced a plan that could save state residents up to 50 percent on some prescription drugs.
The key is reimporting drugs that are sold to Canada […]
‘At the crux of the nation’s first Vioxx-related civil trial under way is whether Merck & Co.’s once lucrative painkiller caused a Texas man’s 2001 death from arrhythmia.
While the New Jersey pharmaceutical giant pulled the drug from the market last year after a study showed it doubled the risk of heart attack or stroke if […]
‘Teva Pharmaceutical Industries Ltd. has agreed to buy rival Ivax Corp. for $7.4 billion in a deal that vaults the Israeli firm back to the position as world’s biggest maker of generic drugs.
Teva said on Monday it would buy Ivax for $26 a share, or 0.8471 in Teva American depositary receipts, under the stock-and-cash deal, […]
‘Chemicals and pharmaceuticals firm Merck KGaA saw turnover rise but pretax earnings dip in the second quarter of 2005, although the results were skewed by the gain from its divestment of its laboratory distribution business VWR Interational.
Second-quarter turnover rose 8.6 per cent to €1.48 billion, while operating profit rose 14.9 per cent to €202.9m. Net […]
‘Aradigm Corporation and APT Pharmaceuticals have moved an aerosolized formulation of an anti-inflammatory agent into phase II clinical trials. The partnership will test the drug in Aradigm’s AERx pulmonary delivery system as a new class of treatment for asthma and chronic obstructive pulmonary disease.
As part of the APT-funded program, Aradigm will source the active pharmaceutical […]